David Hovland
Consigliere Generale presso ELEDON PHARMACEUTICALS, INC.
Posizioni attive di David Hovland
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ELEDON PHARMACEUTICALS, INC. | Consigliere Generale | 19/04/2021 | - |
Storia della carriera di David Hovland
Precedenti posizioni note di David Hovland
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| UROVANT SCIENCES LTD. | Consigliere Generale | 01/04/2018 | 01/04/2021 |
| ALLERGAN PLC | Consigliere Generale | 01/01/2015 | 01/01/2018 |
| Corporate Officer/Principal | 01/01/2010 | 01/01/2015 | |
| AMGEN INC. | Consigliere Generale | 01/01/2006 | 01/01/2010 |
| ALLERGAN PLC | Corporate Officer/Principal | 01/01/1999 | 01/01/2002 |
Formazione di David Hovland
| University of California, Los Angeles | Doctorate Degree |
| University of California, Berkeley | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
| Regno Unito | 2 |
| Irlanda | 2 |
Posizioni
| General Counsel | 4 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| ELEDON PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Urovant Sciences Ltd.
 Urovant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Urovant Sciences Ltd. is a clinical-stage biopharmaceutical company, which through its subsidiaries, engages in the development and commercialization of therapies for urologic conditions. Its pipeline includes Vibegron (RVT-901) and URO-902. The company was founded on January 27, 2016 and is headquartered in London, the United Kingdom. | Health Technology |
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
- Borsa valori
- Insiders
- David Hovland
- Esperienza
